Acrivon Therapeutics, Inc. (ACRV) SEC Filings — 2025
11 SEC filings for Acrivon Therapeutics, Inc. (ACRV) in 2025.
Filings
- Acrivon Narrows Q3 Loss Amidst Cash Burn, Clinical Progress — 10-Q · Nov 13, 2025
- Acrivon Therapeutics, Inc. 8-K Filing — 8-K · Sep 5, 2025
- Acrivon Therapeutics Files 8-K — 8-K · Aug 13, 2025
- Acrivon's Losses Widen Amid Increased R&D for Cancer Therapies — 10-Q · Aug 13, 2025
- Acrivon Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
- Acrivon Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Acrivon Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 25, 2025
- Acrivon Therapeutics Files 8-K — 8-K · Apr 7, 2025
- Acrivon Therapeutics, Inc. 10-K Filing — 10-K · Mar 27, 2025
- Acrivon Therapeutics Files 8-K on Financials and Operations — 8-K · Mar 25, 2025
- Acrivon Therapeutics Reports Officer/Director Changes & Compensation — 8-K · Mar 14, 2025